Eli Lilly CEO: The Weight-Loss Drug Revolutio...

We've curated a special 10-minute version of the podcast for those in a hurry. Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/xiaomi-cfo-from-smartphones-to-evs-speed-to-market-and-ai/id1614211565?i=1000762993636&l=nbIn this episode of In Good Comp ...  Show more

In this episode of In Good Company, Nicolai Tangen speaks with Alain Lam, CFO of Xiaomi, about the company’s journey from a smartphone startup to a global technology leader spanning smart devices, electric vehicles, and AI.Lam shares how Xiaomi’s focus on high-quality products at ...  Show more

In this episode of the What the FinTech? podcast, host and FinTech Futures editor Paul Hindle is joined by Paul Noble, CEO of Chetwood Bank, to explore how the Wrexham-based bank has set about its product and tech innovation strategy as it looks to continue its growth trajectory, ...  Show more

In this episode, Ray and Peter discuss the changing world order, China vs. the USA, and Ray’s thoughts on the future of the US. Recorded on Feb 3rd, 2025 Views are my own thoughts; not Financial, Medical, or Legal Advice. Ray Dalio is a renowned investor, hedge fund manager, an ...  Show more

(0:00) Introducing Eli Lilly CEO Dave Ricks

(1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China

(7:08) GLP-1 pricing and capital allocation after a breakout pharma product

(12:56) Why Biotech VC has plummeted, " ...

In this episode of Deciphered, Jeff Tijssen, partner and global head of Fintech, Bain & Company is joined by Georgios Kolovos, EMEA Payments & Fintech Leader, NVIDIA and Phoebe Wallis, Chief Revenue Officer, Griffin to discuss what’s next for Fintech.

Timestamps: